Company intelligence / Profile preview

TR Bio

San Francisco, California, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

TR Bio is a biotechnology company focused on the development of innovative therapeutic solutions for oncology and infectious diseases. The company leverages its expertise in drug discovery and development to identify and advance novel small molecule and biologic candidates. TR Bio aims to address significant unmet medical needs through a robust pipeline of early-stage programs. The company is currently in the pre-clinical stage, working towards identifying lead candidates for clinical evaluation.

Therapeutic areas: Infectious DiseasesOncology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on TR Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TR Bio.

Explore the full profile